⌘K

Login Start Free

Home/Filings/4/0000810084-10-000020

4//SEC Filing

Makar Ralph 4

Accession 0000810084-10-000020

CIK 0000810084other

View on SEC.gov Company Profile

Filed

Oct 3, 8:00 PM ET

Accepted

Oct 4, 9:13 PM ET

Size

8.3 KB

Accession

0000810084-10-000020

Insider Transaction Report

Form 4

Period: 2010-10-01

BIOJECT MEDICAL TECHNOLOGIES INCBJCT

CEO/President

Transactions

Exercise/Conversion
BJCT Common Stock
2010-10-01+33,334→ 827,368 total
Exercise/Conversion
Restricted Stock Unit
2010-10-01−33,334→ 50,000 total
From: 2010-10-01→ BJCT Common Stock (33,334 underlying)

Holdings

BJCT Common Stock
(indirect: By 401(k))
113,930

Footnotes (4)

[F1]1/3 vesting per Executive Employment Agreement dated October 1, 2007.
[F2]Each Restricted Stock Unit represents a contingent right to receive one share of BJCT Common Stock.
[F3]No expiration date.
[F4]Includes Series F Preferred Stock 67,600, Warrant 6,667. Option (Right-to-buy) 480,000, Restricted Stock Unit 50,000.

Documents

1 file

4
primary_doc.xmlPrimary
PRIMARY DOCUMENT

Issuer

BIOJECT MEDICAL TECHNOLOGIES INC

CIK 0000810084

Entity typeother

Related Parties

1

filerCIK 0001414579

Filing Metadata

Form type: 4
Filed: Oct 3, 8:00 PM ET
Accepted: Oct 4, 9:13 PM ET
Size: 8.3 KB

View on SEC.gov